drugset / Trial / NCT00828438
Pharmacokinetic Properties of Lorcaserin in Subjects With Renal Impairment
NaSingle-groupOpen-labelOther
Summary
The purpose of this study is to evaluate the PK properties of lorcaserin in subjects with end stage renal disease (ESRD) who require dialysis and will be studied under dialysis and non-dialysis conditions.
Timeline
- Start
- 2008-10
- Primary completion
- 2009-02
- Completion
- 2009-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lorcaserin | Small molecule | 10 mg | — |